Key genes altered in glioblastoma based on bioinformatics (Review)

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Glioblastoma multiforme (GBM) is an aggressive brain tumor characterized by a poor prognosis.
• Understanding the genetic underpinnings of GBM is crucial for developing effective treatments.

Purpose of the Study:

• To leverage bioinformatics to identify key genetic alterations and signaling pathways involved in GBM development and progression.
• To uncover novel therapeutic targets for GBM based on genomic data analysis.

Main Methods:

• Analysis of extensive genomic data from GBM samples.
• Identification and characterization of significantly altered signaling pathways (e.g., PI3K/AKT/mTOR, Ras/Raf/MEK/ERK).
• Pinpointing key driver genes (e.g., EGFR, TP53, TERT).

Main Results:

• Identification of critical signaling pathways (PI3K/AKT/mTOR, Ras/Raf/MEK/ERK) implicated in GBM.
• Discovery of key genes (EGFR, TP53, TERT) driving tumor progression.
• Enhanced understanding of GBM molecular biology.

Conclusions:

• Bioinformatics is essential for deciphering GBM's genetic complexity.
• Identified pathways and genes represent promising therapeutic targets for GBM.
• Integration of bioinformatics advances treatment strategies and offers hope for improved patient outcomes.